INSIGHTS ON DRUG DEVELOPMENT

• Building A Human-Centric Future For Biologics Development

  Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.

• Lipid Formulation Development: Why Softgels Are The Technology Of Choice

  Low bioavailability affects roughly 80% of APIs, yet many drug developers default to standard OSD forms. This paper examines why softgels deserve earlier consideration in formulation strategy.

• Biologic Stability: A Thermofluor Screen For Rational Buffer Optimization

  Learn how thermal shift fluorimetry (thermofluor) can be used as a rapid, low-volume, and cost-effective technique to accelerate buffer optimization and enhance protein stability.

• Overcome Early Development Challenges Before They Impact Your Program

  Poor manufacturability and immunogenicity can delay development. Learn how early developability assessments support IND readiness.

• Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines

  3/24/2025

  Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.

• Quality Time With Oliver: Guest - Andy Goll

  10/5/2026

  Blow-fill-seal technology enables custom single-dose liquid packaging for surgical applications, accommodating viscous liquids, emulsions, and suspensions that standard formats cannot handle.

• Assess Biomolecular Stability With Confidence

  9/15/2026

  Gain deeper insight into biomolecular stability with highly sensitive thermal analysis. Thermodynamic measurements help evaluate formulation performance, detect structural changes, and more.

• Advancing The Human Liver-Chip Toward FDA Qualification

  9/30/2026

  Explore how human-relevant liver models can improve DILI risk assessment and support stronger development decisions while advancing toward regulatory qualification and scaling into automated studies.

• Can Collaboration Close Biopharma's Talent Gap For Good?

  3/17/2026

  Biopharma innovation is accelerating, but workforce shortages threaten progress. See how strengthening collaboration is essential to developing the skills needed for emerging therapies.